1. Home
  2. CWBC vs SLN Comparison

CWBC vs SLN Comparison

Compare CWBC & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Community West Bancshares

CWBC

Community West Bancshares

N/A

Current Price

$25.81

Market Cap

729.1M

Sector

Finance

ML Signal

N/A

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$13.35

Market Cap

678.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWBC
SLN
Founded
1989
1994
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
729.1M
678.0M
IPO Year
2000
2010

Fundamental Metrics

Financial Performance
Metric
CWBC
SLN
Price
$25.81
$13.35
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$28.63
$42.60
AVG Volume (30 Days)
241.3K
1.6M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.03%
N/A
EPS Growth
344.44
N/A
EPS
0.61
N/A
Revenue
N/A
$559,000.00
Revenue This Year
$39.58
N/A
Revenue Next Year
$17.64
N/A
P/E Ratio
$42.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.79
$4.19
52 Week High
$28.17
$17.58

Technical Indicators

Market Signals
Indicator
CWBC
SLN
Relative Strength Index (RSI) 54.69 56.45
Support Level $24.75 $5.24
Resistance Level $27.95 $17.58
Average True Range (ATR) 0.50 1.00
MACD 0.08 -0.09
Stochastic Oscillator 84.21 36.20

Price Performance

Historical Comparison
CWBC
SLN

About CWBC Community West Bancshares

Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments. The company has one reportable segment: Banking operations. Loans and leases, investment securities, interest-bearing deposits and non-interest income provide the revenues of the banking operation.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: